Hatteras Venture Partners is a venture capital firm established in 2000. The firm was founded by Clay B. Thorp and John Crumpler. It operates from its headquarters in Durham, North Carolina. As of March 2019, the firm has 44 active companies in its portfolio and has sold off its ownership in 35 companies. It has most recently invested in Kymera on November 2018, a company specializing in the development of biotechnology to treat untreatable diseases.
Hatteras Venture Partners’ primary investment focus is in companies providing products and services in the field of biopharmaceuticals, medical devices, diagnostic, healthcare information technology and medicine sectors. The firm funds companies in various stages of development, from early stage to mid-venture. It prefers to fund companies operating from the Southeastern states of the U.S., such as North Carolina. Its latest funding round was held in January 2017, which managed to amass a total of $150 million.
A company developing small molecule therapies to treat cancer
Orig3n is a biotechnology company developing personalized regenerative medicine treatments based on patient genetic profiles.
PerkinElmer is a biotechnology company founded by Richard Scott Perkin working on developing detection, imaging, informatics, and service capable technologies.
Rodin Therapeutics is a biotechnology company developing treatments for Alzheimer's disease that is headquartered in Cambridge, Massachusetts and was founded in 2013 by Ankit Mahadevia and Martin Jefson.
SugarSync is a San Mateo, California-based file sharing company founded in 2009 by https://angel.co/ben-strong, https://angel.co/ben-strong and https://angel.co/ben-strong.
A clinical research organization that gives services to rising pharmaceutical, biotechnology and medical device companies
Kymera Therapeutics is a Cambridge, Massachusetts-based biotechnology company specialized in the field of targeted protein degradation.
Wildflower Health is a San Francisco-based company founded by Leah Sparks.
A biopharmaceutical company that develops drugs for the treatment of cardiovascular diseases, endocrine and other metabolic disorders
Qvella is a Richmond Hill, Ontario-based molecular diagnostics company producing medical diagnostic devices and related supplies founded in 2009 by Tino Alavie.
A company developing opthalmic therapeutic products
Genecentric Diagnostics, Inc. is a Durham, North Carolina-based company developing drug response biomarkers for genomic-defined cancer subtypes founded in 2011.
Atsena Therapeutics, Inc. is a Durham, North Carolina-based company.
NeuroTronik is a Durham, North Carolina-based company founded in 2012 by William Starling.
StrideBio, Inc. is a gene therapy company focused on creating and developing novel adeno-associated viral (AAV) vector technologies.
410 Medical is a Durham, North Carolina-based company founded in 2013.
Christy L. Shaffer
Clay B. Thorp
Documentaries, videos and podcasts